CRISPR/Cas13 sgRNA‐Mediated RNA–RNA Interaction Mapping in Live Cells with APOBEC RNA Editing
Advanced Science · 2024
DOI: 10.1002/advs.202409004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Li-Ting Diao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, RNA Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Program for Guangdong Introducing Innovative and Entrepreneurial Teams, Natural Science Foundation of Guangdong.
Abstract (Originalsprache)
Current research on long non‐coding RNA (lncRNA) has predominantly focused on identifying their protein partners and genomic binding sites, leaving their RNA partners largely unknown. To address this gap, the study has developed a method called sarID (sgRNA scaffold assisted RNA‐RNA interaction detection), which integrates Cas13‐based RNA targeting, sgRNA engineering, and proximity RNA editing to investigate lncRNA‐RNA interactomes. By applying sarID to the lncRNA NEAT1 , over one thousand previously unidentified binding transcripts are discovered. sarID is further expanded to investigate binders of XIST , MALAT1, NBR2 , and DANCR , demonstrating its broad applicability in identifying lncRNA‐RNA interactions. The findings suggest that lncRNAs may regulate gene expression by interacting with mRNAs, expanding their roles beyond known functions as protein scaffolds, miRNA sponges, or guides for epigenetic modulators. sarID has the potential to be adapted for studying other specific RNAs, providing a novel immunoprecipitation‐free method for uncovering RNA partners and facilitating the exploration of the RNA‐RNA interactome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapy Center, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China.
- Institute of Vaccine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China.
- Reforgene Medicine, Guangzhou, 510535, P. R. China.
- Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China.
ORCID-Profile: Zhen-Dong Xiao
Förderung
- National Natural Science Foundation of China
- Program for Guangdong Introducing Innovative and Entrepreneurial Teams
- Natural Science Foundation of Guangdong
- Science and Technology Projects in Guangzhou
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Diao, L. T., Xie, S. J., Xu, W. Y., Zhang, H. H., Hou, Y. R., Hu, Y. X., Liang, X. X., Liang, J. B., Zhang, Q., & Xiao, Z. D. (2024). CRISPR/Cas13 sgRNA‐Mediated RNA–RNA Interaction Mapping in Live Cells with APOBEC RNA Editing. Advanced Science. https://doi.org/10.1002/advs.202409004
Vancouver
Diao LT, Xie SJ, Xu WY, Zhang HH, Hou YR, Hu YX, et al. CRISPR/Cas13 sgRNA‐Mediated RNA–RNA Interaction Mapping in Live Cells with APOBEC RNA Editing. Advanced Science. 2024. doi:10.1002/advs.202409004
BibTeX
@article{Diao2024,
author = {Diao, Li-Ting and Xie, Shu-Juan and Xu, Wan-Yi and Zhang, Hai-Hui and Hou, Ya-Rui and Hu, Yan-Xia and Liang, Xin-Xiang and Liang, Jun-Bin and Zhang, Qi and Xiao, Zhen-Dong},
title = {CRISPR/Cas13 sgRNA‐Mediated RNA–RNA Interaction Mapping in Live Cells with APOBEC RNA Editing},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202409004}
}
EUVIMED